Transplantation Journal Editorial Fellowship

Jeremy Chapman

Editor-in-Chief
Transplantation Journals

The Editors of Transplantation and Transplantation Direct are seeking expressions of interest for the role of Editorial Fellow.

The Fellowship is designed for an early career professional in transplantation interested in being on the frontlines of Transplantation, the most cited journal in transplantation, and Transplantation Direct, our open access journal.

The Fellowship is for two years and designed to provide training and experience in scientific publishing. You will see the inner workings of an academic journal, from recruiting and selecting peer reviewers to participating in publication decisions. There will be 6 Editorial Fellows appointed to the following roles:

  • Journal Monthly Issue’s Fellowship - Assisting the Editor In Chief planning each issue and managing the flow of papers
  • Statistics Fellowship – providing Statistical review, working with the Executive Editor Biostatistics
  • Overviews Fellowship – Developing a pipeline of invited overviews, working with the Executive Director Clinical
  • Three Social Media Fellowships for Transplantation and Transplantation Direct – Working with the Executive Director Basic Science and Social Media Editor to develop Visual Abstracts and Social media messages
  • Special Features Fellowship – Working with the Executive Director Special Features to plan and implement the special features section of the journal

In addition all fellows will assist in the process of peer review and will be involved in executive meetings of the journal to learn how journal decision making operates.

To be considered for the Fellowship, applicants will have a demonstrated commitment to a career in transplantation and probably be a recent graduates of surgical or medical residencies or have completed post-doctoral studies or research fellowship. Applicants will have excellent writing ability and strong communication skills. You will respect deadlines since the journal will not wait for you, so the ability to carve out time in your busy clinical and academic schedules will be a skill that you will need to have or be prepared to develop.

We invite applications from interested candidates. Please submit your letter or video application with your CV to editorialoffice@journal.tts.org. The deadline for applications is 15th November 2023. When writing your application please identify which of the roles you would like to be involved in and we recommend that thought be given to the art of saying more with less.


TTS News

TTS @ ESOT 2023

TTS was at ESOT 2023 from September 17-20 to promote our TTS 2024 Congress and we took this unique opportunity to hold a Scientific Program Committee meeting to address key topics, identify emerging trends, and carefully curate an engaging program for TTS 2024. More updates on TTS 2024 are coming soon!

TTS @ ISOT 2023

TTS had a strong delegation attending the 33rd Annual Conference of the Indian Society of Organ Transplant, which was held in Kolkata from October 5-8
Vivek Kute (TTS Councilor), Jeremy Chapman (Transplantation Journals Editor-in-Chief). Stefan Tullius (TTS Vice President)
Vivek Kute (TTS Councilor) and Elmi Muller (TTS President)

Spotlighted News

Monkey survives for two years after gene-edited pig-kidney transplant

Oct 11 - Nature - A kidney transplanted from a genetically engineered miniature pig kept a monkey alive for more than two years — one of the longest survival times for an interspecies organ transplant. This is a “proof of principle in non-human primates to say our [genetically engineered] organ is safe and supports life”, says Wenning Qin, who co-authored the study published in Nature on 11 October.

Trial Results Indicate Potential for Organ Transplantation Without Long-Term Immunosuppression

Oct 10 - The early-stage clinical trial results by University of Pittsburgh School of Medicine scientists, reported today in Science Translational Medicine, point to a path that may spare organ transplant recipients from the serious side effects of long-term immunosuppressant use, which can include cancer, diabetes, kidney failure and susceptibility to infections.

TTS By-laws revision and Business Meeting

October 23, 2023 08:00 AM (Montreal Time)

TTS invites all members to a short virtual business meeting to share the results of the member vote on the eight proposed TTS by-law amendments.

Read more about the "2023 Proposed TTS By-law Changes". Vote open until October 21!

Last Chances for Upcoming Meetings!

SPLIT 2023 - Starts Monday!

October 16-17, 2023
Montreal, Canada
27th Annual Meeting of the Society of Pediatric Liver Transplantation

ISODP 2023 - Last Chance to Register!

October 18-21, 2023
Las Vegas, USA
16th Congress of the International Society for Organ Donation and Procurement

IPITA-IXA-CTRMS Joint Congress
Last Chance to Register!

October 26-29, 2023
San Diego, USA
Joint Congress of the
International Pancreas and Islet Association,
International Xenotransplantation Association,
and the Cell Transplant and Regenerative Medicine Society

BCD 2023
Oct. 20 - Abstract Deadline

November 29-30, 2023
Ankara, Turkey
International Symposium on “Brain Death and Circulatory Death”

TTS-ISN Sister Centers Application Submission - Deadline October 15!

Thanks to a partnership with The Transplantation Society (TTS), this program pairs up emerging transplant centers with established centers so they can benefit from educational support and work together to increase opportunities for kidney transplant patients in low-resource countries.

Transplantation Journal Highlights

Transplantation - Highlighted Tweets

Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference
Small-for-size syndrome (SFSS) is a well-recognized complication following liver transplantation (LT), with up to 20% developing this following living donor LT (LDLT). Preventing SFSS involves consideration of factors before the surgical procedure, including donor and recipient selection, and factors during the surgical procedure, including adequate outflow reconstruction, graft portal inflow modulation, and management of portosystemic shunts. International Liver Transplantation Society, International Living Donor Liver Transplantation Group, and Liver Transplant Society of India Consensus Conference was convened in January 2023 to develop recommendations for the prediction and management of SFSS in LDLT.
Proteomics: Its Promise and Pitfalls in Shaping Precision Medicine in Solid Organ Transplantation
The past decade has seen an increased number of efforts to develop minimally invasive procedures for monitoring allograft injury. Despite the recent progress, limitations such as the complexity of proteomics-based technology, the lack of standardization, and the heterogeneity of populations that have been included in different studies have hindered proteomic tools from reaching clinical transplantation. This review focuses on the role of proteomics-based platforms in biomarker discovery and validation in solid organ transplantation. We also emphasize the value of biomarkers that provide potential mechanistic insights into the pathophysiology of allograft injury, dysfunction, or rejection.

Transplantation Direct - Highlighted Tweet

Transplantation Direct - October 2023
Decreased Lymphocytic Bronchitis Severity in the Era of Azithromycin Prophylaxis
Large-airway lymphocytic inflammation (LB), assessed on endobronchial biopsies, has been associated with acute cellular rejection and chronic lung allograft dysfunction (CLAD). Azithromycin (AZI) prophylaxis has been used to prevent airway inflammation and subsequent CLAD, with inconsistent results. We hypothesized that AZI prophylaxis would be associated with reduced LB, changes in bronchoalveolar lavage (BAL) immune cell populations, and improved CLAD-free survival.

In the News 


Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada